Your browser doesn't support javascript.
loading
Mesenchymal stem cells and immune disorders: from basic science to clinical transition / 医学前沿
Frontiers of Medicine ; (4): 138-151, 2019.
Article in En | WPRIM | ID: wpr-771295
Responsible library: WPRO
ABSTRACT
As a promising candidate seed cell type in regenerative medicine, mesenchymal stem cells (MSCs) have attracted considerable attention. The unique capacity of MSCs to exert a regulatory effect on immunity in an autologous/allergenic manner makes them an attractive therapeutic cell type for immune disorders. In this review, we discussed the current knowledge of and advances in MSCs, including its basic biological properties, i.e., multilineage differentiation, secretome, and immunomodulation. Specifically, on the basis of our previous work, we proposed three new concepts of MSCs, i.e., "subtotipotent stem cell" hypothesis, MSC system, and "Yin and Yang" balance of MSC regulation, which may bring new insights into our understanding of MSCs. Furthermore, we analyzed data from the Clinical Trials database ( http://clinicaltrials.gov ) on registered clinical trials using MSCs to treat a variety of immune diseases, such as graft-versus-host disease, systemic lupus erythematosus, and multiple sclerosis. In addition, we highlighted MSC clinical trials in China and discussed the challenges and future directions in the field of MSC clinical application.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Physiology / Randomized Controlled Trials as Topic / Cell Differentiation / Mesenchymal Stem Cell Transplantation / Regenerative Medicine / Allergy and Immunology / Mesenchymal Stem Cells / Immune System Diseases Type of study: Clinical_trials Limits: Humans Language: En Journal: Frontiers of Medicine Year: 2019 Type: Article
Full text: 1 Index: WPRIM Main subject: Physiology / Randomized Controlled Trials as Topic / Cell Differentiation / Mesenchymal Stem Cell Transplantation / Regenerative Medicine / Allergy and Immunology / Mesenchymal Stem Cells / Immune System Diseases Type of study: Clinical_trials Limits: Humans Language: En Journal: Frontiers of Medicine Year: 2019 Type: Article